Strumento inattivo

Altre lingue First Light Acquisition Group, Inc. Nyse

Azioni

FLAG.U

US3207032000

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board	14:01
Calidi Biotherapeutics, Inc. Enters into A Certain Loan Agreement with Dennis R. Conklin	08/07
Calidi to Effect Reverse Stock Split	08/07
Calidi Biotherapeutics to Implement 1-For-10 Reverse Stock Split	05/07
Calidi to Effect Reverse Stock Split	05/07
Calidi Biotherapeutics, Inc. announced that it has received $0.6 million in funding	02/07
Calidi Biotherapeutics, Inc. announced that it expects to receive $0.6 million in funding	01/07
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors	27/06
Calidi Biotherapeutics, Inc. Appoints George E. Peoples to Its Board of Directors	27/06
Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13	11/06
Sector Update: Health Care Stocks Advance Late Afternoon	10/06
Sector Update: Health Care	10/06
Calidi Biotherapeutics Signs Virotherapy Deal With Siga Technologies -- Calidi Shares Surge Pre-Bell	10/06
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors	10/06
Calidi Biotherapeutics Collaborates with Siga Technologies to Advance Calidi?S Revolutionary Rtnova Virotherapy for Lung Cancer and Metastatic Solid Tumors	10/06
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting	03/06
Calidi Biotherapeutics Presents Cld-101 Phase 1 Trial Update and Preclinical Data Highlighting Rtnova and Cld-201 At 2024 Asco Annual Meeting	03/06
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds	31/05
Calidi Biotherapeutics, Inc. Announces Resignation of David Lapre as Director	16/05
Calidi Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue First Light Acquisition Group, Inc. Nyse

Azioni

FLAG.U

US3207032000

Altre lingue

Filtri